Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Myla, Goldman"'
Autor:
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, Jeffrey A Cohen, Jorge Correale, Jennifer Graves, Ruth Ann Marrie, Xavier Montalban, V Wee Yong, Alan J Thompson, Daniel S Reich, Maria Pia Amato, Brenda Banwell, Frederik Barkhof, Jeremy Chataway, Tanuja Chitnis, Giancarlo Comi, Tobias Derfuss, Marcia Finlayson, Myla Goldman, Ari Green, Kerstin Hellwig, Daphne Kos, Aaron Miller, Ellen Mowry, Jiwon Oh, Amber Salter, Maria Pia Sormani, Mar Tintore, Helen Tremlett, Maria Trojano, Anneke van der Walt, Sandra Vukusic, Emmaunelle Waubant
Publikováno v:
International Advisory Committee on Clinical Trials in Multiple Sclerosis 2023, ' Multiple sclerosis progression : time for a new mechanism-driven framework ', The Lancet Neurology, vol. 22, no. 1, pp. 78-88 . https://doi.org/10.1016/S1474-4422(22)00289-7
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-remitting, secondary progressive, and primary progressive—for patient care, research, and regulatory approval of medications. Accumulating evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c95d190a07ae620fd13c1f9545253e9
https://doi.org/10.1016/s1474-4422(22)00289-7
https://doi.org/10.1016/s1474-4422(22)00289-7
Publikováno v:
INNOVATIONS in Pharmacy, Vol 11, Iss 2 (2020)
Background: Comprehensive care of people with multiple sclerosis integrates disease modifying therapy, symptom management and minimization of risk factors for disease progression. Cigarette smoking is a modifiable risk factor associated with developm
Externí odkaz:
https://doaj.org/article/9e27ef603ba3424aa6a0173e85d890ce
Autor:
Deborah A, Hall, Carolyn, Cahill, Ana-Claire L, Meyer, Amanda, Peltier, Marisela, Dy-Hollins, Myla, Goldman
Publikováno v:
Neurology. 100:e454-e464
Background and ObjectivesTo assess gender disparities in neurology researcher careers in the United States.MethodsA 34-question survey was distributed to 4,644 US-based American Academy of Neurology members who self-identified as researchers in 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e183fdef83bc156243ed61e730169491
https://doi.org/10.1212/wnl.0000000000200773
https://doi.org/10.1212/wnl.0000000000200773
Autor:
Jacob Perlman, Diana Lehner-Gulotta, Emma Wetmore, Rachael Coleman, Brenda Banwell, A. G. Bergqvist, Shanshan Chen, Mark Conaway, Myla Goldman, Anne Marie Morse, James Brenton
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23c51e36e9c3d76799bac08dfa68efe5
https://doi.org/10.1212/wnl.0000000000202949
https://doi.org/10.1212/wnl.0000000000202949
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85d4586c4d91b39b3f9f7fc000ec0ed8
https://doi.org/10.1212/wnl.0000000000203210
https://doi.org/10.1212/wnl.0000000000203210
Publikováno v:
EAI Endorsed Transactions on Pervasive Health and Technology, Vol 2, Iss 5, Pp 1-7 (2016)
Walking ability can be degraded by a number of pathologies, including movement disorders, stroke, and injury. Personal activity tracking devices gather inertial data needed to measure walking quality, but the required algorithmic methods are an activ
Externí odkaz:
https://doaj.org/article/a9df8d6ad6f74255b941a7ecf637aa91
Autor:
J. Nicholas Brenton, Brian Florenzo, Hitoshi Koshiya, Seulgi Min, Emma Woolbright, Rachael Coleman, Shanshan Chen, Myla Goldman
Publikováno v:
Neurology
BACKGROUND:Despite low levels of disability, youth with pediatric-onset MS (POMS) engage in less physical activity compared to peers. The contribution of walking capacity, endurance, behavior, and MS co-morbidities remain relatively undefined and may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ecb1f9746025cb846f8e40ed47aed4
https://europepmc.org/articles/PMC9651457/
https://europepmc.org/articles/PMC9651457/
Publikováno v:
EAI Endorsed Transactions on Internet of Things, Vol 2, Iss 7 (2016)
Gait assessment using inertial body sensors is becoming popular as an outcome measure in multiple sclerosis (MS) research, supplementing clinical observations and patient-reported outcomes with precise, objective measures. Although numerous research
Externí odkaz:
https://doaj.org/article/25ac8439a0dc4c1883e5f50e72ce9cf3
Autor:
Raju Kapoor, Pei-Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L Arnold, Mark S Freedman, Myla D Goldman, Hans-Peter Hartung, Eva Kubala Havrdová, Douglas Jeffery, Aaron Miller, Finn Sellebjerg, Diego Cadavid, Dan Mikol, Deborah Steiner, Emmanuel Bartholomé, Marie D'Hooghe, Massimo Pandolfo, Bart Van Wijmeersch, Virender Bhan, Gregg Blevins, Donald Brunet, Virginia Devonshire, Pierre Duquette, Mark Freedman, François Grand'Maison, François Jacques, Yves Lapierre, Liesly Lee, Sarah Morrow, Michael Yeung, Michal Dufek, Petr Kanovsky, Ivana Stetkarova, Marika Talabova, Jette Frederiksen, Matthias Kant, Thor Petersen, Mads Ravnborg, Laura Airas, Irina Elovaara, Juha-Pekka Eralinna, Taneli Sarasoja, Abdullatif Al Khedr, David Brassat, Bruno Brochet, William Camu, Marc Debouverie, David Laplaud, Christine Lebrun Frenay, Jean Pelletier, Patrick Vermersch, Sandra Vukusi, Karl Baum, Achim Berthele, Juergen Faiss, Peter Flachenecker, Reinhard Hohlfeld, Markus Krumbholz, Christoph Lassek, Mathias Maeurer, Sven Meuth, Tjalf Ziemssen, Orla Hardiman, Christopher McGuigan, Anat Achiron, Dimitrios Karussis, Roberto Bergamaschi, Vincenzo Brescia Morra, Giancarlo Comi, Salvatore Cottone, Luigi Grimaldi, Giovanni Luigi Mancardi, Luca Massacesi, Ugo Nocentini, Marco Salvetti, Elio Scarpini, Patrizia Sola, Gioacchino Tedeschi, Maria Trojano, Mauro Zaffaroni, Stephan Frequin, Raymond Hupperts, Joep Killestein, Hans Schrijver, Ronald Van Dijl, Erik van Munster, Maciej Czarnecki, Wieslaw Drozdowski, Waldemar Fryze, Hanka Hertmanowska, Jan Ilkowski, Anna Kaminska, Gabriela Klodowska-Duda, Maciej Maciejowski, Ewa Motta, Ryszard Podemski, Andrzej Potemkowski, Teresa Rog, Krzysztof Selmaj, Zbigniew Stelmasiak, Adam Stepien, Andrzej Tutaj, Jacek Zaborski, Alexey Boyko, Zanna Chefranova, Evgeny Evdoshenko, Farit Khabirov, Stella Sivertseva, Eduard Yakupov, Jose Carlos Alvarez Cermeño, Antonio Escartin, Oscar Fernandez Fernandez, Antonio Garcia-Merino, Miguel Angel Hernandez Perez, Guillermo Izquierdo Ayuso, José Meca Lallana, Xavier Montalban Gairin, Celia Oreja-Guevara, Albert Saiz Hinarejos, Martin Gunnarsson, Jan Lycke, Claes Martin, Fredrik Piehl, Homayoun Roshanisefat, Peter Sundstrom, Martin Duddy, Bruno Gran, Timothy Harrower, Jeremy Hobart, Martin Lee, Paul Mattison, Richard Nicholas, Owen Pearson, Waqar Rashid, David Rog, Basil Sharrack, Eli Silber, Ben Turner, Anna Williams, John Woolmore, Carolyn Young, Daniel Bandari, Joseph Berger, Ann Camac, Stanley Cohan, Jill Conway, Keith Edwards, Michelle Fabian, Jack Florin, Steven Freedman, Dennis Garwacki, Myla Goldman, Daniel Harrison, Craig Herrman, Deren Huang, Adil Javed, Stephen Kamin, George Katsamakis, Bhupendra Khatri, Annette Langer-Gould, Sharon Lynch, David Mattson, Tamara Miller, Augusto Miravalle, Harold Moses, Suraj Muley, James Napier, Allen Nielsen, Andrew Pachner, Gabriel Pardo, MaryAnn Picone, Derrick Robertson, Walter Royal, Christopher Sheppard, Ben Thrower, Cary Twyman, Emmanuelle Waubant, Jeanette Wendt, Vijayshree Yadav, Rana Zabad, Greg Zarelli
Publikováno v:
The Lancet Neurology
The Lancet Neurology, 2018, 17 (5), pp.405-415. ⟨10.1016/S1474-4422(18)30069-3⟩
Petersen, T & ASCEND investigators 2018, ' Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension ', Lancet Neurology, vol. 17, no. 5, pp. 405-415 . https://doi.org/10.1016/S1474-4422(18)30069-3
The Lancet Neurology, 2018, 17 (5), pp.405-415. ⟨10.1016/S1474-4422(18)30069-3⟩
Petersen, T & ASCEND investigators 2018, ' Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension ', Lancet Neurology, vol. 17, no. 5, pp. 405-415 . https://doi.org/10.1016/S1474-4422(18)30069-3
BACKGROUND: Although several disease-modifying treatments are available for relapsing multiple sclerosis, treatment effects have been more modest in progressive multiple sclerosis and have been observed particularly in actively relapsing subgroups or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc95b87ac32870a3b8f8710dac67e04
https://doi.org/10.1016/s1474-4422(18)30069-3
https://doi.org/10.1016/s1474-4422(18)30069-3
Autor:
Joanna Suski, Myla Goldman
Publikováno v:
Journal of Neurology & Neurophysiology.
Symptomatic retrochiasmatic lesions due to demyelinating disease are rare in multiple sclerosis. The most common cause of visual disturbance in multiple sclerosis is optic neuritis which typically presents with pain around the eye that worsens with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c00791fdaf85a0ccb29f8cf841fce64
https://doi.org/10.4172/2155-9562.s12-014
https://doi.org/10.4172/2155-9562.s12-014